Triple vessel disease refers to significant coronary artery disease involving the three major coronary territories, commonly the left anterior descending, left circumflex, and right coronary arteries. It usually develops from atherosclerotic plaque buildup and may reduce blood supply to the heart. Treatment depends on the extent and location of blockages, symptoms, heart function, and overall health.
Timely treatment can improve blood flow to the heart, control symptoms, reduce the risk of heart attack and heart failure, and help prevent further cardiovascular complications. Early assessment also helps determine whether medical therapy, angioplasty and stenting, or coronary artery bypass grafting (CABG) is most appropriate.
Causes
Risk Factors
Coronary Artery Bypass Grafting (CABG) : Often preferred for patients with complex multivessel disease, particularly when diabetes, high anatomical complexity, or other factors favour surgery. The decision should be made by a multidisciplinary heart team.
Cost Start From 6400Explore Options
Angioplasty and Stenting: May be considered for selected patients when the coronary anatomy is suitable for PCI, particularly when surgical risk is high, or disease complexity is lower.
Hybrid or Minimally Invasive Procedures: In selected patients, a combination of minimally invasive bypass surgery and PCI may be considered when it offers advantages over either approach alone.
MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive tele-rehabilitation services designed to support Triple Vessel Disease patients in Malaysia. These services include:









Kuala Lumpur, Malaysia
Parkway Pantai located in Kuala Lumpur, Malaysia is accredited by JCI. Also listed below are some of the most prominent infrastructural details:

Kuala Lumpur, Malaysia
Sunway Medical Centre has initiated a comprehensive expansion plan close to its current hospital facility to enhance its ability to provide services to the global market. The new Cancer Radiosurgery Center and Nuclear Medicine Center, which will also house additional Centers of Excellence like the Digestive Health Center and Dialysis Center, marked the completion of Tower C's first phase in October 2016.

Petaling Jaya, Malaysia
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome

Pragun Gupta is a Doctor of Pharmacy (Pharm. D.) professional from Teerthanker Mahaveer University with hands-on experience in clinical pharmacology, clinical research, and evidence-based medical writing. Through her clinical and research exposure, she has developed a strong interest in pharmacoeconomics, pharmacology, therapeutics, and pharmacovigilance.
As a medical writer, she works on medical and scientific research articles, patient education materials, and healthcare-focused content. Her clinical research and evidence-based writing experience enables her to translate complex medical information into clear, accurate, patient-friendly content while maintaining scientific credibility and medical accuracy. Her primary aim is to make healthcare information accessible and easy for patients and general readers to understand.
View More
Interventional Cardiologist
29 Years of Experience
With a rich experience of more than 29 years, Dr. Nityanand has gained a vast spectrum of skills and expertise in performing all types of complex cardiac procedures. He is an expert in clinical & interventional cardiology and electrophysiology. He studied his medicine (MBBS) and MD from the Institute of Medical Sciences of Banaras Hindu University, Varanasi, and later completed his DM in Cardiology from the prestigious King George Medical University, Lucknow. View More
Last Reviewed - January 2026